Table 1

Clinical data on the patients included in the study (studied for serum CA 125)a

No. of marrow transplants (no. of patients)32 (29)
Female/male ratio14/15
Mean age, yr (range)6.2 (0.1–17.2)
Diagnosis (no. of patients)
Acute lymphoblastic leukemia9
Acute myelogenous leukemia3
Lymphoma2
Neuroblastoma4
Retinoblastoma1
Small round cell tumor2
Other solid tumor3
Osteopetrosis3
Kostman’s syndrome1
Combined immunodeficiency1
BMTs (no. of transplants)b
Allogeneic (HLA matched/HLA mismatched)3/15
Autologous14
  • a Twenty-two of the patients were the same as in a study previously reporting serum procollagen type III as a marker of VOD (6) .

  • b Allogeneic donors were considered matched if identical at HLA loci A, B, C, and DRB1.